Probiotics in reducing anxiety and depression symptoms: an integrative review

Detalhes bibliográficos
Autor(a) principal: Costa, Bruna Cunha
Data de Publicação: 2020
Outros Autores: Azevedo, George Silva dos Santos, Ferreira, Pedro Henrique Arruda, Rodrigues Almeida, Leila Magda
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Ciências em Saúde
Texto Completo: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014
Resumo: Objectives: To summarize studies that evaluated probiotic supplementation as a therapeutic strategy for anxiety and depression symptoms. Methods: An integrative review of articles indexed in the PubMed, SciELO and Virtual Health Library databases published between January 2010 and September 2019. For this purpose, the combination of descriptors: “intestine”, “brain”, “Intestinal microbiota”, “anxiety”, “depression”, “probiotics”, in Portuguese and English. Results: After applying the inclusion and exclusion criteria, 13 randomized clinical trials were selected. The duration of the studies in its majority was 8 or 12 weeks (61.5%; n = 8), and the most offered form of the supplement was the probiotic powder (46.2%; n = 6) and capsule (30.8%; n = 4). Regarding the use of scales as a parameter for assessing symptoms of anxiety and depression, 38.5% (n = 5) used only one scale and 69.2% (n = 8) used the combination of two or three scales. Regarding the genus of bacteria, most studies used Lactobacillus and Bifidobacterium together (53.8%; n = 7). Despite methodological limitations and inconsistent results, most clinical trials (76.92%; n = 10) showed a significant reduction in symptoms related to anxiety and depression through probiotic supplementation. Conclusion: The evidence indicates that supplementation with probiotics has a potential in reducing symptoms of anxiety and depression, however further research is needed on this strategy as an adjunctive therapy in effective treatment for mental health.
id RCS_e4bcbe79b8e8c78235fda356f5080f64
oai_identifier_str oai:ojs.portalrcs.hcitajuba.org.br:article/1014
network_acronym_str RCS
network_name_str Revista Ciências em Saúde
repository_id_str
spelling Probiotics in reducing anxiety and depression symptoms: an integrative reviewProbióticos na redução de sintomas de ansiedade e depressão: uma revisão integrativaanxietydepressionintestinal microbiotaprobioticsansiedadedepressãomicrobiota intestinalprobióticosObjectives: To summarize studies that evaluated probiotic supplementation as a therapeutic strategy for anxiety and depression symptoms. Methods: An integrative review of articles indexed in the PubMed, SciELO and Virtual Health Library databases published between January 2010 and September 2019. For this purpose, the combination of descriptors: “intestine”, “brain”, “Intestinal microbiota”, “anxiety”, “depression”, “probiotics”, in Portuguese and English. Results: After applying the inclusion and exclusion criteria, 13 randomized clinical trials were selected. The duration of the studies in its majority was 8 or 12 weeks (61.5%; n = 8), and the most offered form of the supplement was the probiotic powder (46.2%; n = 6) and capsule (30.8%; n = 4). Regarding the use of scales as a parameter for assessing symptoms of anxiety and depression, 38.5% (n = 5) used only one scale and 69.2% (n = 8) used the combination of two or three scales. Regarding the genus of bacteria, most studies used Lactobacillus and Bifidobacterium together (53.8%; n = 7). Despite methodological limitations and inconsistent results, most clinical trials (76.92%; n = 10) showed a significant reduction in symptoms related to anxiety and depression through probiotic supplementation. Conclusion: The evidence indicates that supplementation with probiotics has a potential in reducing symptoms of anxiety and depression, however further research is needed on this strategy as an adjunctive therapy in effective treatment for mental health.Objetivos: sumarizar estudos que avaliaram a suplementação de probióticos como estratégia terapêutica nos sintomas da ansiedade e depressão. Métodos: revisão integrativa de artigos indexados na base de dados PubMed, SciELO e Biblioteca Virtual em Saúde publicados de janeiro de 2010 a setembro de 2019. Para isso, utilizou-se a conjugação dos descritores: “intestino”, “cérebro”, “microbiota intestinal”, “ansiedade”, “depressão”, “probióticos”, nos idiomas português e inglês. Resultados: Após a aplicação dos critérios de inclusão e exclusão, 13 ensaios clínicos randomizados foram selecionados. O tempo de duração dos estudos, em sua maioria, foi de 8 ou 12 semanas (61,5%; n = 8), e a forma mais ofertada do suplemento foi o probiótico em pó (46,2%; n = 6) e em cápsula (30,8%; n = 4). Sobre a utilização de escalas como parâmetro de avaliação dos sintomas de ansiedade e depressão, 38,5% (n = 5) utilizaram apenas uma escala e 69,2% (n = 8) utilizaram a combinação de duas ou três escalas. Em relação ao gênero das bactérias, a maior parte dos estudos utilizou Lactobacillus e Bifidobacterium em conjunto (53,8%; n = 7). Apesar das limitações metodológicas e dos resultados inconsistentes, a maioria dos ensaios clínicos (76,9%; n = 10) evidenciaram uma redução significativa dos sintomas relacionados à ansiedade e depressão através da suplementação de probióticos. Conclusão: As evidências indicam que a suplementação com probióticos apresenta potencial promissor na redução dos sintomas de ansiedade e depressão, no entanto são necessárias pesquisas adicionais sobre essa estratégia como terapia adjuvante no tratamento efetivo para a saúde mental.AISI/HCI2020-12-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer reviewedAvaliado pelos parestextoinfo:eu-repo/semantics/otherapplication/pdftext/htmltext/xmlhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/101410.21876/rcshci.v10i4.1014Revista Ciências em Saúde; v. 10 n. 4 (2020): Outubro a Dezembro de 2020; 97-108Health Sciences Journal; Vol 10 No 4 (2020): October to December 2020; 97-1082236-378510.21876/rcshci.v10i4reponame:Revista Ciências em Saúdeinstname:Hospital de Clínicas de Itajubáinstacron:HCIporhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/619https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/654https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/655Copyright (c) 2020 Revista Ciências em Saúdehttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessCosta, Bruna CunhaAzevedo, George Silva dos SantosFerreira, Pedro Henrique ArrudaRodrigues Almeida, Leila Magda2021-01-16T05:06:29Zoai:ojs.portalrcs.hcitajuba.org.br:article/1014Revistahttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zeroPUBhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/oaircs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br2236-37852236-3785opendoar:2021-01-16T05:06:29Revista Ciências em Saúde - Hospital de Clínicas de Itajubáfalse
dc.title.none.fl_str_mv Probiotics in reducing anxiety and depression symptoms: an integrative review
Probióticos na redução de sintomas de ansiedade e depressão: uma revisão integrativa
title Probiotics in reducing anxiety and depression symptoms: an integrative review
spellingShingle Probiotics in reducing anxiety and depression symptoms: an integrative review
Costa, Bruna Cunha
anxiety
depression
intestinal microbiota
probiotics
ansiedade
depressão
microbiota intestinal
probióticos
title_short Probiotics in reducing anxiety and depression symptoms: an integrative review
title_full Probiotics in reducing anxiety and depression symptoms: an integrative review
title_fullStr Probiotics in reducing anxiety and depression symptoms: an integrative review
title_full_unstemmed Probiotics in reducing anxiety and depression symptoms: an integrative review
title_sort Probiotics in reducing anxiety and depression symptoms: an integrative review
author Costa, Bruna Cunha
author_facet Costa, Bruna Cunha
Azevedo, George Silva dos Santos
Ferreira, Pedro Henrique Arruda
Rodrigues Almeida, Leila Magda
author_role author
author2 Azevedo, George Silva dos Santos
Ferreira, Pedro Henrique Arruda
Rodrigues Almeida, Leila Magda
author2_role author
author
author
dc.contributor.author.fl_str_mv Costa, Bruna Cunha
Azevedo, George Silva dos Santos
Ferreira, Pedro Henrique Arruda
Rodrigues Almeida, Leila Magda
dc.subject.por.fl_str_mv anxiety
depression
intestinal microbiota
probiotics
ansiedade
depressão
microbiota intestinal
probióticos
topic anxiety
depression
intestinal microbiota
probiotics
ansiedade
depressão
microbiota intestinal
probióticos
description Objectives: To summarize studies that evaluated probiotic supplementation as a therapeutic strategy for anxiety and depression symptoms. Methods: An integrative review of articles indexed in the PubMed, SciELO and Virtual Health Library databases published between January 2010 and September 2019. For this purpose, the combination of descriptors: “intestine”, “brain”, “Intestinal microbiota”, “anxiety”, “depression”, “probiotics”, in Portuguese and English. Results: After applying the inclusion and exclusion criteria, 13 randomized clinical trials were selected. The duration of the studies in its majority was 8 or 12 weeks (61.5%; n = 8), and the most offered form of the supplement was the probiotic powder (46.2%; n = 6) and capsule (30.8%; n = 4). Regarding the use of scales as a parameter for assessing symptoms of anxiety and depression, 38.5% (n = 5) used only one scale and 69.2% (n = 8) used the combination of two or three scales. Regarding the genus of bacteria, most studies used Lactobacillus and Bifidobacterium together (53.8%; n = 7). Despite methodological limitations and inconsistent results, most clinical trials (76.92%; n = 10) showed a significant reduction in symptoms related to anxiety and depression through probiotic supplementation. Conclusion: The evidence indicates that supplementation with probiotics has a potential in reducing symptoms of anxiety and depression, however further research is needed on this strategy as an adjunctive therapy in effective treatment for mental health.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-14
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer reviewed
Avaliado pelos pares
texto
info:eu-repo/semantics/other
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014
10.21876/rcshci.v10i4.1014
url https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014
identifier_str_mv 10.21876/rcshci.v10i4.1014
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/619
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/654
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1014/655
dc.rights.driver.fl_str_mv Copyright (c) 2020 Revista Ciências em Saúde
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Revista Ciências em Saúde
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
text/xml
dc.publisher.none.fl_str_mv AISI/HCI
publisher.none.fl_str_mv AISI/HCI
dc.source.none.fl_str_mv Revista Ciências em Saúde; v. 10 n. 4 (2020): Outubro a Dezembro de 2020; 97-108
Health Sciences Journal; Vol 10 No 4 (2020): October to December 2020; 97-108
2236-3785
10.21876/rcshci.v10i4
reponame:Revista Ciências em Saúde
instname:Hospital de Clínicas de Itajubá
instacron:HCI
instname_str Hospital de Clínicas de Itajubá
instacron_str HCI
institution HCI
reponame_str Revista Ciências em Saúde
collection Revista Ciências em Saúde
repository.name.fl_str_mv Revista Ciências em Saúde - Hospital de Clínicas de Itajubá
repository.mail.fl_str_mv rcs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br
_version_ 1797068962813444096